Pharmaceutical Technology on MSN
PRISM BioLab partners with Receptor.AI for molecule discovery
The collaboration targets disease areas where conventional small molecule drug discovery has faced challenges.
Vietnam Investment Review on MSN
PRISM BioLab and Receptor AI partner on drug discovery
TOKYO, March 13, 2026 /PRNewswire/ -- PRISM BioLab Co., Ltd. ("PRISM") and Receptor.AI Inc. today announced that they have entered into a drug discovery collaboration agreement (the "Collaboration") ...
But then again, Valerie Cherish has never been one to rush. When HBO’s The Comeback returns for its third and final season on March 22, it arrives as it always has—exactly on time. The series, ...
Melissa Chambers has had a remarkable journey to founding cybersecurity company Sitehop. She tells Fiona Haran why she could write a book on resilience “Don’t tell me I can’t do something - because ...
Cigna and UnitedHealth cut 5,000 jobs for AI—but healthcare data is workslop. HCA hit record highs by augmenting, not axing.
As conflicts in the Middle East continue to unfold with eerily similar signatures, the echoes of India's Operation Sindoor grow louder. Vishnu Som's new book offers first-person accounts from those at ...
Politicians said every child should be taught coding for future job security, yet AI has made 10,000 Australian programmers redundant ... Read More The post Coding fever: Were our youths sold a ...
Since its debut at Light + Building 2024, the Wellsky series has gained global recognition for combining design aesthetics with optical innovation, winning IF, GOOD DESIGN, and IDEA design awards. The ...
With rising acquisition costs and endless digital competition, traffic's not enough—and creating engagement that converts ...
Nearly 300 abstracts on prostate cancer research from around the world will be presented at the European Association of Urology Congress (EAU26 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results